Research elucidating the pathogenesis of systemic lupus erythematosus (SLE) has defined
two critical families of mediators, type I interferon (IFN-I) and autoantibodies targeting nucleic …

Systemic lupus erythematosus (SLE) is a chronic autoimmune disease. The complex
relationships between race and ethnicity and social determinants of health (SDOH) in …

Abstract Objective Glucocorticoids (“steroids”) are frequently used in systemic lupus
erythematosus (SLE). Prolonged use may contribute to racial/ethnic disparities in avoidable …

Objective The objective of this study was to evaluate the association between frailty status
and risk of readmissions, inpatient death, and cost of admission among patients with …

Objective We aimed to develop readily measurable digital quality measure statements for
clinical care in systemic lupus erythematosus (SLE) using a multistep process guided by …

Objective The present study was undertaken to evaluate high‐quality care delivery in the
context of provider goal‐setting activities and a multidisciplinary care model using an …

Objective To study the association between high quality of care (QOC) and quality of life
(QOL) and nonroutine health care use (HCU) in systemic lupus erythematosus. Methods …

Objective Patients with pediatric systemic lupus erythematosus (pSLE) and mixed
connective tissue disease (MCTD) receive only a fraction of recommended care. Using …

Purpose To assess if high quality of care (QOC) in SLE results in improved outcomes of
quality of life (QOL) and non-routine health care utilization (HCU). Methods One hundred …

Systemic lupus erythematosus (SLE) affects more severely non-White populations, which is
also the case in Latin America; this is the result of a combination of genetic and non-genetic …